A Study of Barzolvolimab in Patients With Prurigo Nodularis

Running, not enrolling · Phase 2 · Has a placebo group

Conditions studied: Prurigo Nodularis

In brief

The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with prurigo nodularis.

Key facts

Study ID
NCT06366750
Run by
Celldex Therapeutics
People needed
140
Starts
2024-04-12
Expected to finish
2027-03-01
Last updated by the study team
2026-08-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.